Schimmelpennink Evert B.

Schimmelpennink Evert B. is listed in filings as President at LENZ Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 30, 2026, including purchase activity. Recent filings connect the profile to LENZ Therapeutics, Inc. (LENZ), iBio, Inc. (IBIO), and Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Jul 23, 2024 to Mar 30, 2026. Reported amounts are shown as $46.8K to $4.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.